A Case of Neisseria sicca Bacteremia Due to Eculizumab Therapy
Eculizumab is a monoclonal antibody indicated for the treatment of complement-mediated disorders. Despite its utility, eculizumab increases risk for infection with Neisseria species, owing to membrane attack complex inhibition. Although this naturally evokes thought of infection with N meningitidis,...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American College of Physicians
2023-06-01
|
| Serie: | Annals of Internal Medicine: Clinical Cases |
| Accesso online: | https://www.acpjournals.org/doi/10.7326/aimcc.2022.0934 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|